HYTENEZE 12.5 |
CAPTOPRIL |
LOPRIL |
HYTENEZE 25 |
KAPLON |
SQ-14225 |
ECOPACE |
CAPTOMEX |
HYTENEZE 50 |
NOYADA |
TENSOBON |
SA-333 |
C09AA01 |
CAPOTEN |
SQ -14225 |
ACEPRIL |
ACEPRESS |
CAPTOPRYL |
CAPOTEN® |
L-CAPTOPRIL |
D-3-MERCAPTO-2-METHYLPROPANOYL-L-PROLINE |
CAPTOLANE |
HYPERTIL |
APOPRIL |
(2S)-1-[(2S)-2-METHYL-3-SULFANYLPROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID |
CAPTORIL |
LOPIRIN |
CP |
D-2-METHYL-3-MERCAPTOPROPANOYL-L-PROLINE |
GARRANIL |
TENSOPREL |
TENOSBON |
CAPTOPRILUM |
CESPLON |
DILABAR |
drugbank:01197 |
rxcui:1998 |
pubchem.compound:44093 |
chembl:CHEMBL1560 |
chemidplus:62571-86-2 |
FDA Approval | 1981 |
Drug Class | small molecule |
Drug Indications | Antihypertensive Agents |
Drug Categories | enzyme inhibitors |
Year of Approval | 1981 |
Drug Class | antihypertensive agents |
Drug Categories | agents causing angioedema |
Drug Categories | agents causing hyperkalemia |
Drug Categories | agents causing muscle toxicity |
Drug Categories | antihypertensive agents indicated for hypertension |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | oat1/slc22a6 substrates |
Drug Categories | oat3/slc22a8 substrates |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | photosensitizing agents |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Direct Interaction | yes |
CAPTOPRIL | DrugBank Drug Name |
62571-86-2 | CAS Number |
Acepress | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | ace inhibitors and diuretics |
CAPTOPRIL | Primary Drug Name |
Drug Class | antihypertensive agents |
Year of Approval | 1981 |
Drug Indications | Antihypertensive Agents |
Drug Class | small molecule |
FDA Approval | 1981 |
C340 | NCI drug code |
CHEMBL1560 | ChEMBL Drug ID |
D0I0EG | TTD Drug ID |
CAPTOPRIL | GuideToPharmacology Ligand Name |